Amphastar Pharmaceuticals's total assets for Q1 2026 were $1.65B, an increase of 1.16% from the previous quarter. AMPH total liabilities were $874.77M for the fiscal quarter, a 4.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.